CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2021				102,959,000	102,959,000
Beginning balance at Dec. 31, 2021	$ 295,913	$ (13,910)	$ 282,003	$ 103	$ 103	$ 2,387,039	$ (32,249)	$ 2,354,790	$ (2,087,957)	$ 18,339	$ (2,069,618)	$ (3,272)	$ (3,272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,311								13,311
Other comprehensive income (loss), net of tax	(9,678)											(9,678)
Issuance of common stock under stock option, award and purchase plans, net (in shares)				2,659,000
Issuance of common stock under award and purchase plans, net	3,047			$ 2		3,045
Repurchase of common stock (in shares)				(557,000)
Repurchase of common stock	(5,013)								(5,013)
Stock-based compensation	13,166					13,166
Ending balance (in shares) at Jul. 01, 2022				105,061,000
Ending balance at Jul. 01, 2022	296,836			$ 105		2,371,001			(2,061,320)			(12,950)
Beginning balance (in shares) at Apr. 01, 2022				104,603,000
Beginning balance at Apr. 01, 2022	284,653			$ 105		2,362,873			(2,073,288)			(5,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	14,840								14,840
Other comprehensive income (loss), net of tax	(7,913)											(7,913)
Issuance of common stock under stock option, award and purchase plans, net (in shares)				782,000
Issuance of common stock under award and purchase plans, net	2,773					2,773
Repurchase of common stock (in shares)				(324,000)
Repurchase of common stock	(2,872)								(2,872)
Stock-based compensation	5,355					5,355
Ending balance (in shares) at Jul. 01, 2022				105,061,000
Ending balance at Jul. 01, 2022	$ 296,836			$ 105		2,371,001			(2,061,320)			(12,950)
Beginning balance (in shares) at Dec. 31, 2022	109,871,000			109,871,000
Beginning balance at Dec. 31, 2022	$ 324,506			$ 110		2,380,651			(2,046,569)			(9,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,648								6,648
Other comprehensive income (loss), net of tax	2,723											2,723
Issuance of common stock under stock option, award and purchase plans, net (in shares)				1,713,000
Issuance of common stock under award and purchase plans, net	$ (4,559)			$ 2		(4,561)
Repurchase of common stock (in shares)	0
Stock-based compensation	$ 13,483					13,483
Ending balance (in shares) at Jun. 30, 2023	111,584,000			111,584,000
Ending balance at Jun. 30, 2023	$ 342,801			$ 112		2,389,573			(2,039,921)			(6,963)
Beginning balance (in shares) at Mar. 31, 2023				111,332,000
Beginning balance at Mar. 31, 2023	335,786			$ 111		2,384,806			(2,041,476)			(7,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,555								1,555
Other comprehensive income (loss), net of tax	692											692
Issuance of common stock under stock option, award and purchase plans, net (in shares)				252,000
Issuance of common stock under award and purchase plans, net	(1,291)			$ 1		(1,292)
Stock-based compensation	$ 6,059					6,059
Ending balance (in shares) at Jun. 30, 2023	111,584,000			111,584,000
Ending balance at Jun. 30, 2023	$ 342,801			$ 112		$ 2,389,573			$ (2,039,921)			$ (6,963)